The Parkinson’s Foundation is establishing a new program offering genetic testing and counseling to Parkinson’s patients within its Centers of…
Articles by Patricia Inácio, PhD
University of Pennsylvania researchers used a new technology that mimics the way animated movies capture a person’s movement to…
People with Parkinson’s disease are being recruited for a new clinical trial testing nilotinib, an FDA-approved leukemia treatment, in a…
New technology that uses MRI-guided focused ultrasound to target areas of the brain affected by Parkinson’s disease and improve…
Cardiolipin, a molecule inside nerve cells, may be a key player behind nerve cell death in Parkinson’s disease, a study…
Genervon Biopharmaceuticals announced its future goals for investigational therapy GM6 in a recent presentation on its multi-target drug development…
Mutations in mitochondria, which result in a shortage of energy, may be an underlying cause of movement difficulties associated with…
A new personalized medical strategy that can replicate human biological systems in a small chip may help predict patients’ response…
The venom of the emerald cockroach wasp is capable of triggering Parkinson’s-like features, particularly problems controlling movement, a California study…
The U.S. Food and Drug Administration (FDA) has approved Osmolex ER (amantadine, extended release) to treat both Parkinson’s disease and therapy-induced…